The US Food and Drug Administration (FDA) has approved sodium thiosulfate (Pedmark, Fennec Pharmaceuticals) injection to reduce the risk for ototoxicity associated with cisplatin in pediatric patients ...

City of Hope to Evaluate PEDMARK® for Reducing Ototoxicity in Adult Men with Stage II-III Metastatic Testicular Germ Cell Tumors – – Initiation ...

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies Hearing loss occurs in 50%-70% of children treated with ...

Please provide your email address to receive an email when new articles are posted on . AUSTIN, Texas — Use of sodium thiosulfate to treat calciphylaxis in patients on peritoneal dialysis can be ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Sodium thiosulfate, administered before and after reperfusion for STEMI, did not improve infarct ...

SCOTTSDALE, AZ--(Marketwired - Aug 2, 2013) - Hope Pharmaceuticals today announced that the United States Patent and Trademark Office issued U. S. patent no. 8,496,973, titled "Sodium ...

RESEARCH TRIANGLE PARK, N.C., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the U.S.

Study, Which Enrolled 27 Patients, Met Primary Endpoint with a Significant Reduction in Hearing Loss in 3-18 Year Old Patients who Received ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DBL Sodium Thiosulfate Injection contains the active ingredient sodium ...

Sodium thiosulfate showed no benefits for reducing injury to damaged areas of heart muscle following a heart attack, in a study presented at the American College of Cardiology's 71 st Annual ...